Diarreia do viajante

Referências

Principais artigos

Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl 1):S57-74.Texto completo  Resumo

De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev. 2000;(3):CD002242.Texto completo  Resumo

Johnson PC, Ericsson CD, DuPont HL, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA. 1986 Feb 14;255(6):757-60. Resumo

Artigos de referência

1. Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl 1):S57-74.Texto completo  Resumo

2. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009 Apr;80(4):609-14. Resumo

3. Jiang ZD, DuPont HL. Etiology of travellers' diarrhea. J Travel Med. 2017 Apr 1;24(suppl_1):S13-S16.Texto completo  Resumo

4. Barrett J, Brown M. Travellers' diarrhoea. BMJ. 2016 Apr 19;353:i1937. Resumo

5. Ashbaugh HR, Early JM, Johnson ME, et al. A Multisite Network Assessment of the Epidemiology and Etiology of Acquired Diarrhea among U.S. Military and Western Travelers (Global Travelers' Diarrhea Study): A Principal Role of <i>Norovirus</i> among Travelers with Gastrointestinal Illness. Am J Trop Med Hyg. 2020 Nov;103(5):1855-1863.Texto completo  Resumo

6. Connor BA; Centers for Disease Control and Prevention. Traveler's health: Persistent diarrhea in returned travelers. Jun 2019 [internet publication].Texto completo

7. Lalani T, Maguire JD, Grant EM, et al. Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries. J Travel Med. 2015 May-Jun;22(3):152-60.Texto completo  Resumo

8. Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015 Jan 6;313(1):71-80. Resumo

9. Steffen R, Tornieporth N, Clemens SA, et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med. 2004 Jul-Aug;11(4):231-7.Texto completo  Resumo

10. DuPont H, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med. 1993 Jun 24;328(25):1821-7. Resumo

11. Lääveri T, Vilkman K, Pakkanen SH, et al. A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions. Clin Microbiol Infect. 2017 Nov 10;24(8):908.e9-16. Resumo

12. Duplessis CA, Gutierrez RL, Porter CK. Review: chronic and persistent diarrhea with a focus in the returning traveler. Trop Dis Travel Med Vaccines. 2017 May 4;3:9.Texto completo  Resumo

13. U.S. Food and Drug Administration. Bad bug book: handbook of foodborne pathogenic microorganisms and natural toxins. Second edition. 2012 [internet publication].Texto completo

14. Bacaner N, Stauffer B, Boulware D, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004 Jun 16;291(23):2856-64.Texto completo  Resumo

15. Connor BA; Centers for Disease Control and Prevention. Travelers’ diarrhea in CDC Yellow Book 2020: health information for international travel. June 2019 [internet publication].Texto completo

16. Hu Y, Ren J, Zhan M, et al. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Travel Med. 2012 Dec;19(6):352-6.Texto completo  Resumo

17. Alajbegovic S, Sanders JW, Atherly DE, et al. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis. Syst Rev. 2012 Aug 28;1:39.Texto completo  Resumo

18. Martinez-Sandoval F, Ericsson CD, Jiang ZD, et al. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010 Mar-Apr;17(2):111-7.Texto completo  Resumo

19. DuPont HL, Ericsson CD, Johnson PC, et al. Prevention of traveler's diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987 Mar 13;257(10):1347-50. Resumo

20. Brum JM, Gibb RD, Ramsey DL, et al. Systematic review and meta-analyses assessment of the clinical efficacy of bismuth subsalicylate for prevention and treatment of infectious diarrhea. Dig Dis Sci. 2020 Aug 8;:.Texto completo  Resumo

21. Connor BA, Riddle MS. Post-infectious sequelae of travelers' diarrhea. J Travel Med. 2013 Sep-Oct;20(5):303-12.Texto completo  Resumo

22. Vila J. New molecular diagnostic tools in traveller's diarrhea. J Travel Med. 2017 Apr 1;24(suppl 1):S23-28.Texto completo  Resumo

23. Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Texto completo  Resumo

24. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev. 2000;(3):CD002242.Texto completo  Resumo

25. Kantele A, Lääveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015 Mar 15;60(6):837-46.Texto completo  Resumo

26. Connor BA, Keystone JS. Antibiotic self-treatment of travelers' diarrhea: helpful or harmful? Clin Infect Dis. 2015 Mar 15;60(6):847-8.Texto completo  Resumo

27. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. 21 March 2019 [internet publication].Texto completo

28. US Food & Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 12 May 2016 [internet publication].Texto completo

29. US Food & Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication].Texto completo

30. US Food & Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 20 December 2018 [internet publication].Texto completo

31. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 19 March 2019 [internet publication].Texto completo

32. Bruzzese E, Giannattasio A, Guarino A. Antibiotic treatment of acute gastroenteritis in children. F1000Res. 2018 Feb 15;7:193.Texto completo  Resumo

33. Johnson PC, Ericsson CD, DuPont HL, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA. 1986 Feb 14;255(6):757-60. Resumo

34. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis. 2008 Oct 15;47(8):1007-14.Texto completo  Resumo

35. Riddle MS, Sanders JW, Putnam SD, et al. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg. 2006 May;74(5):891-900.Texto completo  Resumo

36. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication].Texto completo

37. US Food and Drug Agency. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Texto completo

38. Nee J, Salley K, Ludwig AG, et al. Randomized clinical trial: Crofelemer treatment in women with diarrhea-predominant irritable bowel syndrome. Clin Transl Gastroenterol. 2019 Dec;10(12):e00110.Texto completo  Resumo

39. Macarthur RD, Hawkins TN, Brown SJ, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study. HIV Clin Trials. 2013 Nov-Dec;14(6):261-73.Texto completo  Resumo

40. Guo Q, Goldenberg JZ, Humphrey C, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019 Apr 30;(4):CD004827.Texto completo  Resumo

41. Pérez-Gaxiola G, Cuello-García CA, Florez ID, et al. Smectite for acute infectious diarrhoea in children. Cochrane Database Syst Rev. 2018 Apr 25;4:CD011526.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal